The effects on diet, anastomotic type, and LOXIGLUMIDE (cas 107097-80-3) on gastric emptying following gastrojejunostomy
-
Add time:08/10/2019 Source:sciencedirect.com
PurposeThe effects on gastric emptying of feeding with a normal diet (ND), an early high-calorie and hyperosmolar diet (HCHOD) or normal diet plus intraperitoneal LOXIGLUMIDE (cas 107097-80-3) (LOX) were investigated in rats with antecolic (ACGJ) or retrocolic (RCGJ) gastrojejunostomy.
We also recommend Trading Suppliers and Manufacturers of LOXIGLUMIDE (cas 107097-80-3). Pls Click Website Link as below: cas 107097-80-3 suppliers
Prev:Adenosine triphosphate-selective fluorescent turn-on response of a novel THIAZOLE ORANGE (cas 107091-89-4) derivative via their cooperative co-assembly
Next:Use of a Hepta-Tyr antibiotic modified silica stationary phase for the enantiomeric resolution of d) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- LOXIGLUMIDE (cas 107097-80-3) inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans08/16/2019
- Satiety effects of the type A CCK receptor antagonist LOXIGLUMIDE (cas 107097-80-3) in lean and obese women08/15/2019
- Treatment with cholecystokinin receptor antagonist LOXIGLUMIDE (cas 107097-80-3) enhances insulin response to intravenous glucose stimulation in postpancreatitic rats08/14/2019
- Effect of the specific cholecystokinin-receptor antagonist LOXIGLUMIDE (cas 107097-80-3) on bombesin stimulated pancreatic enzyme secretion in man08/13/2019
- A cholecystokinin receptor antagonist, LOXIGLUMIDE (cas 107097-80-3), stimulates biliary secretion in conscious rats08/12/2019
- Use of a Hepta-Tyr antibiotic modified silica stationary phase for the enantiomeric resolution of d08/11/2019